PTM Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

PTM Therapeutics General Information

Description

Developer of a post-translational modification technology designed for disease-specific targets on therapeutic antibodies. The company's technology is used to distinguish healthy cells or tissues from diseased cells or tissues and is important in various biological dysfunctions, enabling pharmaceutical developers to discover targets and develop new therapeutics for the treatment of chronic diseases and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PTM Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
1. Early Stage VC 01-Jan-2020 Completed Pre-Clinical Trials
To view PTM Therapeutics’s complete valuation and funding history, request access »

PTM Therapeutics Patents

PTM Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260174847-A1 Methods of treating digestive diseases and compositions thereof Pending 21-Aug-2023
WO-2025042888-A1 Methods of treating digestive diseases and compositions thereof Inactive 21-Aug-2023
AU-2023204801-A1 Methods of treating solid tumors and compositions thereof Pending 06-Jan-2022
EP-4460331-A1 Methods of treating solid tumors and compositions thereof Pending 06-Jan-2022
US-20250064966-A1 Methods of treating solid tumors and compositions thereof Pending 06-Jan-2022 A61K47/6851
To view PTM Therapeutics’s complete patent history, request access »

PTM Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PTM Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Springboard Enterprises Accelerator/Incubator Minority
Biobrit Venture Capital Minority
BioRock Ventures Venture Capital Minority
Innovation Partnerships Venture Capital Minority
To view PTM Therapeutics’s complete investors history, request access »

PTM Therapeutics FAQs

  • When was PTM Therapeutics founded?

    PTM Therapeutics was founded in 2019.

  • Where is PTM Therapeutics headquartered?

    PTM Therapeutics is headquartered in San Carlos, CA.

  • What is the size of PTM Therapeutics?

    PTM Therapeutics has 2 total employees.

  • What industry is PTM Therapeutics in?

    PTM Therapeutics’s primary industry is Drug Discovery.

  • Is PTM Therapeutics a private or public company?

    PTM Therapeutics is a Private company.

  • What is PTM Therapeutics’s current revenue?

    The current revenue for PTM Therapeutics is .

  • Who are PTM Therapeutics’s investors?

    Springboard Enterprises, Biobrit, BioRock Ventures, and Innovation Partnerships have invested in PTM Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process